Literature DB >> 31478070

Response to "Comment on Wang et al.: One-stage posterior focus debridement, interbody graft using titanium mesh cages, posterior instrumentation and fusion in the surgical treatment of lumbo-sacral spinal tuberculosis in the aged".

Hong-Qi Zhang1,2, Weiwei Liao3, Yu-Xiang Wang4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31478070     DOI： 10.1007/s00264-019-04407-w

Source DB:  PubMed          Journal:  Int Orthop        ISSN： 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  6 in total

1.  Comment on Wang et al.: One-stage posterior focus debridement, interbody graft using titanium mesh cages, posterior instrumentation and fusion in the surgical treatment of lumbo-sacral spinal tuberculosis in the aged.

Authors:  Haibo Li; Qingyi Dong
Journal:  Int Orthop       Date:  2016-04-25       Impact factor: 3.075

2.  One-stage posterior focus debridement, interbody graft using titanium mesh cages, posterior instrumentation and fusion in the surgical treatment of lumbo-sacral spinal tuberculosis in the aged.

Authors:  Yu-Xiang Wang; Hong-Qi Zhang; Weiwei Liao; Ming-Xing Tang; Chao-Feng Guo; Ang Deng; Jian-Huang Wu; Jin-Yang Liu
Journal:  Int Orthop       Date:  2016-03-17       Impact factor: 3.075

Review 3.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

Review 4.  Clinical management of combined tuberculosis and diabetes.

Authors:  R van Crevel; R Koesoemadinata; P C Hill; A D Harries
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

Review 5.  Drug therapy in spinal tuberculosis.

Authors:  S Rajasekaran; Gaurav Khandelwal
Journal:  Eur Spine J       Date:  2012-05-12       Impact factor: 3.134

6.  Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.

Authors:  Xin-Tong Lv; Xi-Wei Lu; Xiao-Yan Shi; Ling Zhou
Journal:  J Int Med Res       Date:  2017-03-27       Impact factor: 1.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.